Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: HeyRainier who wrote (1159)	6/23/1998 11:30:00 AM
From: Joe	Respond to of 4140

Visx will probably not have to go through three phases of clinicals. The first phase is to show safety, which they have already done with myopia. The second phase is to show efficacy and to provide data showing that the procedure warrants moving into testing on a larger population of subjects where they can access long term efficacy. My guess is that they will only have the equivalent of Phase III. This could probably be completed in the timeframe that was stated. Secondly, the CEO of Laser Vision Centers would not have made the statement unless they are very confident in it actually happening. As anyone in the medical device business knows, predicting when the FDA takes an action is usually wrong. He would not have made a public statement like that unless they have some reason to believe it's true.